Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
VERV holding history
Verve Therapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VERV overviewAll 13F holders of VERVFull Q4 2025 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −4,191,854−100.0% | Sold out | Holders |
| Q2 2025 | 4,191,854 | $47.1M | <0.1% | +236,755+6.0% | Added | Holders |
| Q1 2025 | 3,955,099 | $18.1M | <0.1% | −51,535−1.3% | Reduced | Holders |
| Q4 2024 | 4,006,634 | $22.6M | <0.1% | +1,4730.0% | Added | Holders |
| Q3 2024 | 4,005,161 | $19.4M | <0.1% | −1,258,348−23.9% | Reduced | Holders |
| Q2 2024 | 5,263,509 | $25.7M | <0.1% | −1,067,803−16.9% | Reduced | Holders |
| Q1 2024 | 6,331,312 | $84.1M | <0.1% | +859,382+15.7% | Added | Holders |
| Q4 2023 | 5,471,930 | $76.3M | <0.1% | +638,962+13.2% | Added | Holders |
| Q3 2023 | 4,832,968 | $64.1M | <0.1% | +741,753+18.1% | Added | Holders |
| Q2 2023 | 4,091,215 | $76.7M | <0.1% | +212,365+5.5% | Added | Holders |
| Q1 2023 | 3,878,850 | $55.9M | <0.1% | +66,826+1.8% | Added | Holders |
| Q4 2022 | 3,812,024 | $73.8M | <0.1% | +153,212+4.2% | Added | Holders |
| Q3 2022 | 3,658,812 | $125.7M | <0.1% | +1,316,619+56.2% | Added | Holders |
| Q2 2022 | 2,342,193 | $35.8M | <0.1% | +23,418+1.0% | Added | Holders |
| Q1 2022 | 2,318,775 | $52.9M | <0.1% | +954,554+70.0% | Added | Holders |
| Q4 2021 | 1,364,221 | $50.3M | <0.1% | +81,679+6.4% | Added | Holders |
| Q3 2021 | 1,282,542 | $60.3M | <0.1% | +1,217,542+1,873.1% | Added | Holders |
| Q2 2021 | 65,000 | $3.92M | <0.1% | +65,000 | New | Holders |